- Medpace Holdings Inc. beats first-quarter earnings expectations by $0.61 per share.
- Analysts predict a potential 23.50% upside in stock price over the next year.
- GuruFocus estimates a 36.72% upside in GF Value for Medpace within one year.
Medpace Holdings Inc. (MEDP) has reported outstanding financial results for the first quarter, achieving a net income of $114.6 million, equivalent to $3.67 per share. This impressive performance topped analyst predictions of $3.06 per share. Additionally, the company's revenue also surpassed expectations, coming in at $558.6 million. Looking ahead, Medpace is forecasting full-year earnings in the range of $12.26 to $13.04 per share, whilst projecting revenue between $2.14 billion and $2.24 billion.
Wall Street Analysts Forecast
Wall Street analysts have set a positive tone for Medpace Holdings Inc. (MEDP) with a one-year average price target of $330.33. This target is derived from estimates by 10 analysts, suggesting a potential upside of 23.50% from its current trading price of $267.47. The highest estimate is pegged at $404.00, while the lowest stands at $280.00. For investors seeking more in-depth information, additional estimates are available on the Medpace Holdings Inc. (MEDP, Financial) Forecast page.
Brokerage analysts maintain a "Hold" status for Medpace with an average recommendation score of 2.6, based on 11 brokerage firm inputs. This rating lies in the middle of a scale where 1 represents a Strong Buy and 5 indicates a Sell.
GuruFocus GF Value Estimation
According to GuruFocus GF Value estimates, Medpace Holdings Inc. (MEDP, Financial) exhibits a projected GF Value of $365.69 for the coming year. This implies a potential upside of 36.72% from its current price of $267.47. The GF Value metric evaluates the stock’s fair trading value based on historical multiples, past growth, and future performance forecasts. For more comprehensive insights, details are available on the Medpace Holdings Inc. (MEDP) Summary page.
By strategically engaging with these projections and analyses, investors can gain a clearer understanding of Medpace Holdings Inc.'s potential trajectory, aligning their investment strategies accordingly.
